furosemide has been researched along with Alcoholic Cirrhosis in 24 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was undertaken to determine whether or not spironolactone could induce drug-metabolizing enzymes in patients with ascites due to alcoholic cirrhosis of the liver." | 9.05 | Spironolactone and enzyme induction in patients with alcoholic cirrhosis. ( Dhumeaux, D; Joanne, C; Miguet, JP; Thebault-Lucas, A; Vuitton, D, 1980) |
| "We have studied the efficacy of urea in the treatment of hyponatremia and hydrosaline retention in cirrhotic patients with ascites resistant to diuretics." | 7.67 | Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea. ( Cauchie, P; Decaux, G; Delwiche, F; Flamion, B; Mols, P, 1986) |
| "The present study was undertaken to determine whether or not spironolactone could induce drug-metabolizing enzymes in patients with ascites due to alcoholic cirrhosis of the liver." | 5.05 | Spironolactone and enzyme induction in patients with alcoholic cirrhosis. ( Dhumeaux, D; Joanne, C; Miguet, JP; Thebault-Lucas, A; Vuitton, D, 1980) |
| "Twenty-seven patients with nonazotemic liver cirrhosis and ascites were initially treated with spironolactone, 200 mg/day." | 3.70 | Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients. ( Banić, M; Kujundzić, M; Ljubicić, N; Vrkljan, M, 1998) |
| "We have studied the efficacy of urea in the treatment of hyponatremia and hydrosaline retention in cirrhotic patients with ascites resistant to diuretics." | 3.67 | Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea. ( Cauchie, P; Decaux, G; Delwiche, F; Flamion, B; Mols, P, 1986) |
| " Bioavailability of 58% +/- 17% (range, 37% to 82%) was comparable to that of previous studies, and there was no difference between patients with mild and those with severe cirrhosis." | 2.67 | Furosemide absorption in patients with cirrhosis. ( Brater, DC; Fredrick, MJ; Hall, SD; Pound, DC, 1991) |
| "Bumetanide and frusemide were compared in a crossover study of 10 patients with cirrhosis and fluid overload." | 2.64 | Treatment of fluid retention in cirrhosis: a comparison of bumetanide and frusemide. ( Nicholson, G, 1977) |
| "The origin of the pleural effusion is a decompensated liver cirrhosis without ascites." | 1.32 | [Massive unilateral hydrothorax as clinical manifestation of decompensated liver cirrhosis without ascites]. ( Camartin, C; Kuhn, M; Reinhart, WH, 2003) |
| "Drug-induced hepatic encephalopathy was more common in cirrhotics receiving diuretics (13." | 1.27 | An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease. ( Busto, U; Janecek, E; Kaplan, K; Naranjo, CA; Roach, CA; Ruiz, I, 1983) |
| " Furosemide bioavailability was the same in cirrhotic subjects and controls." | 1.26 | Furosemide disposition in cirrhotic patients. ( Blaschke, TF; Gregory, PB; Sawhney, VK; Swezey, SE, 1981) |
| "In two patients, renal tubular acidosis (RTA) was observed." | 1.26 | [Study of the renal tubular function in alcoholic hepatic cirrhosis (author's transl)]. ( Arnalich, F; Barbado, J; García Puig, J; Gil Aguado, A; Martínez Gómez, ME; Mateos Antón, F; Montero García, A; Vázquez, JJ, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (75.00) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perri, GA | 1 |
| Camartin, C | 1 |
| Reinhart, WH | 1 |
| Kuhn, M | 1 |
| Pérez-Ayuso, RM | 2 |
| Arroyo, V | 2 |
| Planas, R | 2 |
| Gaya, J | 1 |
| Bory, F | 1 |
| Rimola, A | 2 |
| Rivera, F | 1 |
| Rodés, J | 2 |
| Naranjo, CA | 1 |
| Busto, U | 1 |
| Janecek, E | 1 |
| Ruiz, I | 1 |
| Roach, CA | 1 |
| Kaplan, K | 1 |
| Nanji, AA | 1 |
| Blank, D | 1 |
| Pierrot, M | 1 |
| Blaise, M | 1 |
| Pourriat, JL | 1 |
| Rathat, C | 1 |
| Cupa, M | 1 |
| Decaux, G | 2 |
| Dumont, I | 1 |
| Naeije, N | 1 |
| Mols, P | 2 |
| Melot, C | 1 |
| Mockel, J | 1 |
| Sawhney, VK | 1 |
| Gregory, PB | 1 |
| Swezey, SE | 1 |
| Blaschke, TF | 1 |
| García Puig, J | 1 |
| Mateos Antón, F | 1 |
| Martínez Gómez, ME | 1 |
| Gil Aguado, A | 1 |
| Barbado, J | 1 |
| Arnalich, F | 1 |
| Montero García, A | 1 |
| Vázquez, JJ | 1 |
| Miguet, JP | 1 |
| Vuitton, D | 1 |
| Thebault-Lucas, A | 1 |
| Joanne, C | 1 |
| Dhumeaux, D | 1 |
| Ljubicić, N | 1 |
| Kujundzić, M | 1 |
| Banić, M | 1 |
| Vrkljan, M | 1 |
| Gentilini, P | 2 |
| Casini-Raggi, V | 1 |
| Di Fiore, G | 1 |
| Romanelli, RG | 1 |
| Buzzelli, G | 1 |
| Pinzani, M | 2 |
| La Villa, G | 2 |
| Laffi, G | 2 |
| Nicholson, G | 1 |
| Peña Yáñez, A | 1 |
| Gil Extremera, B | 1 |
| Bermúdez García, JM | 1 |
| Ramos García, E | 1 |
| Vetter, H | 1 |
| Vetter, W | 1 |
| Beckerhoff, R | 1 |
| Glänzer, K | 1 |
| Furrer, J | 1 |
| Hahn, C | 1 |
| Kolloch, R | 1 |
| Krück, F | 1 |
| Kutz, K | 1 |
| Siegenthaler, W | 1 |
| Witassek, F | 1 |
| Hagège, H | 1 |
| Ink, O | 1 |
| Ducreux, M | 1 |
| Pelletier, G | 1 |
| Buffet, C | 1 |
| Etienne, JP | 1 |
| Fredrick, MJ | 1 |
| Pound, DC | 1 |
| Hall, SD | 1 |
| Brater, DC | 1 |
| Antillon, M | 1 |
| Cominelli, F | 2 |
| Reynolds, TB | 1 |
| Zipser, RD | 1 |
| Tulassay, Z | 2 |
| Tulassay, T | 2 |
| Büki, B | 2 |
| Gohér, A | 1 |
| Wolfgang, R | 1 |
| Szathmári, M | 1 |
| Rascher, W | 1 |
| Meacci, E | 1 |
| Rector, WG | 1 |
| Cauchie, P | 1 |
| Flamion, B | 1 |
| Delwiche, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Success Rate and Complication Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis in Cirrhotic Patients With Ascites[NCT05578573] | 80 participants (Anticipated) | Interventional | 2022-01-17 | Enrolling by invitation | |||
| The Use of Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis: a Multicenter, Open-label Randomized Clinical Trial[NCT01288794] | Phase 4 | 431 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for furosemide and Alcoholic Cirrhosis
| Article | Year |
|---|---|
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
Topics: Ascites; Clinical Trials as Topic; Diuresis; Dose-Response Relationship, Drug; Furosemide; Humans; L | 1983 |
Spironolactone and enzyme induction in patients with alcoholic cirrhosis.
Topics: Adult; Aged; Antipyrine; Body Weight; Drug Interactions; Enzyme Induction; Female; Furosemide; Human | 1980 |
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Topics: Adult; Aged; Ascites; Bed Rest; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Canrenoic Acid; Comb | 1999 |
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Topics: Adult; Aged; Ascites; Bed Rest; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Canrenoic Acid; Comb | 1999 |
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Topics: Adult; Aged; Ascites; Bed Rest; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Canrenoic Acid; Comb | 1999 |
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Topics: Adult; Aged; Ascites; Bed Rest; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Canrenoic Acid; Comb | 1999 |
Treatment of fluid retention in cirrhosis: a comparison of bumetanide and frusemide.
Topics: Adult; Aged; Ascites; Bumetanide; Clinical Trials as Topic; Diuretics; Edema; Female; Furosemide; Hu | 1977 |
[Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
Topics: Aged; Albumins; Ascites; Combined Modality Therapy; Drug Therapy, Combination; Female; Furosemide; H | 1992 |
Furosemide absorption in patients with cirrhosis.
Topics: Absorption; Administration, Oral; Adult; Aged; Furosemide; Humans; Injections, Intravenous; Kidney; | 1991 |
18 other studies available for furosemide and Alcoholic Cirrhosis
| Article | Year |
|---|---|
Ascites in patients with cirrhosis.
Topics: Abdominal Pain; Aged; Analgesics, Opioid; Ascites; Catheters, Indwelling; Diet, Sodium-Restricted; D | 2013 |
[Massive unilateral hydrothorax as clinical manifestation of decompensated liver cirrhosis without ascites].
Topics: Diagnosis, Differential; Diuretics; Exudates and Transudates; Furosemide; Humans; Liver Cirrhosis, A | 2003 |
Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
Topics: Aspirin; Diuresis; Furosemide; Glomerular Filtration Rate; Humans; Kidney; Liver Cirrhosis; Liver Ci | 1983 |
An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease.
Topics: Brain Diseases; Diuretics; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Furosem | 1983 |
Increase in serum alkaline phosphatase owing to furosemide.
Topics: Alkaline Phosphatase; Dose-Response Relationship, Drug; Furosemide; Humans; Liver Cirrhosis, Alcohol | 1982 |
[Early acute pulmonary oedema happening during peritoneovenous by pass (author's transl)].
Topics: Acute Disease; Adult; Cardiac Output; Furosemide; Humans; Liver Cirrhosis, Alcoholic; Male; Middle A | 1981 |
High uric acid and urea clearance in cirrhosis secondary to increased "effective vascular volume".
Topics: Blood Volume; Creatinine; Diuresis; Furosemide; Humans; Isosorbide Dinitrate; Liver Cirrhosis, Alcoh | 1982 |
Furosemide disposition in cirrhotic patients.
Topics: Administration, Oral; Ascites; Biological Availability; Furosemide; Half-Life; Humans; Infusions, Pa | 1981 |
[Study of the renal tubular function in alcoholic hepatic cirrhosis (author's transl)].
Topics: Acidosis, Renal Tubular; Adult; Aged; Blood Flow Velocity; Female; Furosemide; Glomerular Filtration | 1980 |
Predictive factors influencing the therapeutic response to diuretic treatment of ascites in nonazotemic cirrhotic patients.
Topics: Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Liver Cirrhosis, Alcoholi | 1998 |
[Allergic vasculitis after oral administration of furosemide, in a patient with ascitogenic hepatic cirrhosis].
Topics: Administration, Oral; Aged; Drug Hypersensitivity; Female; Furosemide; Humans; Liver Cirrhosis, Alco | 1977 |
[Aldosterone and renin in liver cirrhosis with ascites].
Topics: Aldosterone; Ascites; Furosemide; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Renin; Spiron | 1977 |
Comparative acute effects of diflunisal and indomethacin on renal function in patients with cirrhosis and ascites.
Topics: Diflunisal; Dinoprostone; Diuresis; Drug Interactions; Furosemide; Humans; Indomethacin; Inulin; Kid | 1989 |
[Atrial natriuretic peptides in liver cirrhosis associated with vascular decompensation].
Topics: Atrial Natriuretic Factor; Edema; Female; Furosemide; Glomerular Filtration Rate; Humans; Liver Cirr | 1988 |
Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Creatinine; Diuresis; Female; Furosemide; Hemat | 1988 |
Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Dinoprostone; Diuresis; Female; Furosemide; Humans; Kidne | 1988 |
'Diuretic-resistant' ascites. Observations on pathogenesis.
Topics: Ascites; Diuretics; Drug Resistance; Furosemide; Humans; Hydrostatic Pressure; Kidney; Liver; Liver | 1986 |
Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea.
Topics: Adult; Ascites; Body Weight; Creatinine; Drug Therapy, Combination; Edema; Furosemide; Humans; Hypon | 1986 |